{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:36:22Z","timestamp":1789086982452,"version":"build-2803163510"},"reference-count":78,"publisher":"ARAN Ediciones","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.hipert.2025.06.002","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T20:00:09Z","timestamp":1753473609000},"page":"237-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis and management of diastolic dysfunction in arterial hypertension"],"prefix":"10.20960","volume":"42","author":[{"given":"P.","family":"Blanch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Freixa-Pamias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8588","reference":[{"key":"10.1016\/j.hipert.2025.06.002_bib0395","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mcna.2016.08.013","article-title":"Diastolic dysfunction and hypertension","volume":"101","author":"Nadruz","year":"2017","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.hipert.2025.06.002_bib0400","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jacc.2013.10.063","article-title":"Pre-clinical diastolic dysfunction","volume":"63","author":"Wan","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hipert.2025.06.002_bib0405","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.mcna.2009.02.013","article-title":"Diastolic dysfunction as a link between hypertension and heart failure","volume":"93","author":"Verma","year":"2009","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.hipert.2025.06.002_bib0410","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11906-009-0048-z","article-title":"Therapeutic approaches to diastolic dysfunction","volume":"11","author":"Janardhanan","year":"2009","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.hipert.2025.06.002_bib0415","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2025.06.002_bib0420","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","article-title":"The transition from hypertension to heart failure: contemporary update","volume":"5","author":"Messerli","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0425","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11897-014-0223-7","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"11","author":"Dhingra","year":"2014","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hipert.2025.06.002_bib0430","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.304","article-title":"Heart failure with preserved ejection fraction: uncertainties and dilemmas","volume":"17","author":"Ferrari","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0435","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0440","first-page":"577","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE) dagger","volume":"16","author":"Marwick","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hipert.2025.06.002_bib0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jhh.2014.36","article-title":"Myocardial remodeling in hypertension","volume":"29","author":"Nadruz","year":"2015","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.hipert.2025.06.002_bib0450","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/ajh\/hpv156","article-title":"Prehypertension is associated with abnormalities of cardiac structure and function in the atherosclerosis risk in communities study","volume":"29","author":"Santos","year":"2016","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hipert.2025.06.002_bib0455","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.med.55.091902.104417","article-title":"Left ventricular diastolic dysfunction and diastolic heart failure","volume":"55","author":"Gaasch","year":"2004","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0460","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/HJH.0b013e3282f55038","article-title":"Aortic stiffness for the detection of preclinical left ventricular diastolic dysfunction: pulse wave velocity versus pulse pressure","volume":"26","author":"Abhayaratna","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.hipert.2025.06.002_bib0465","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.116.303596","article-title":"The structural factor of hypertension: large and small artery alterations","volume":"116","author":"Laurent","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.hipert.2025.06.002_bib0470","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJMcp022709","article-title":"Clinical practice. Diastolic heart failure","volume":"351","author":"Aurigemma","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0475","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/hc1102.105289","article-title":"New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0480","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccl.2007.11.001","article-title":"Role of neurohormonal modulators in heart failure with relatively preserved systolic function","volume":"26","author":"Rapp","year":"2008","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.hipert.2025.06.002_bib0485","first-page":"71","article-title":"The role of aldosterone and aldosterone-receptor antagonists in heart failure","volume":"5","author":"Khan","year":"2004","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0490","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajh.2008.16","article-title":"Left ventricular hypertrophy and clinical outcomes in hypertensive patients","volume":"21","author":"Ruilope","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hipert.2025.06.002_bib0495","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1161\/01.CIR.0000019070.70491.6D","article-title":"Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy","volume":"105","author":"Ho","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0500","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/jhh.2011.104","article-title":"Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies","volume":"26","author":"Cuspidi","year":"2012","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.hipert.2025.06.002_bib0505","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ahj.2006.09.013","article-title":"Left ventricular geometric patterns in the Jackson cohort of the Atherosclerotic Risk in Communities (ARIC) study: clinical correlates and influences on systolic and diastolic dysfunction","volume":"153","author":"Fox","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.hipert.2025.06.002_bib0510","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/01.CIR.44.3.446","article-title":"Clinical\u2013physiological correlations in the development of hypertensive heart disease","volume":"44","author":"Frohlich","year":"1971","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0515","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.CIR.34.5.818","article-title":"Electrocardiographic changes reflecting left atrial abnormality in hypertension","volume":"34","author":"Tarazi","year":"1966","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0520","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/HYPERTENSIONAHA.109.146845","article-title":"Size, shape, and stamina: the impact of left ventricular geometry on exercise capacity","volume":"55","author":"Lam","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2025.06.002_bib0525","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.hipert.2017.01.001","article-title":"Diastolic dysfunction in hypertension","volume":"34","author":"Naz\u00e1rio Le\u00e3o","year":"2017","journal-title":"Hipertens Riesgo Vasc"},{"key":"10.1016\/j.hipert.2025.06.002_bib0530","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure \u2013 abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0535","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.hipert.2025.06.002_bib0540","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/HYPERTENSIONAHA.109.138529","article-title":"Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction","volume":"55","author":"Solomon","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.hipert.2025.06.002_bib0545","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","article-title":"Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction","volume":"100","author":"Kalam","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.hipert.2025.06.002_bib0550","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cardfail.2013.12.009","article-title":"Association of left ventricular longitudinal and circumferential systolic dysfunction with diastolic function in hypertension: a nonlinear analysis focused on the interplay with left ventricular geometry","volume":"20","author":"Ballo","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0555","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jacc.2008.04.065","article-title":"Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy","volume":"52","author":"Sharp","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hipert.2025.06.002_bib0560","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hipert.2025.06.002_bib0565","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jcmg.2015.07.004","article-title":"Cardiac imaging to evaluate left ventricular diastolic function","volume":"8","author":"Flachskampf","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hipert.2025.06.002_bib0570","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/ehjci\/jeab154","article-title":"Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging","volume":"23","author":"Smiseth","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hipert.2025.06.002_bib0575","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jcmg.2022.10.011","article-title":"Left atrial strain for assessment of left ventricular diastolic function: focus on populations with normal LVEF","volume":"16","author":"Nagueh","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hipert.2025.06.002_bib0580","doi-asserted-by":"crossref","first-page":"352","DOI":"10.21037\/cdt-24-25","article-title":"Artificial intelligence-enhanced automation of left ventricular diastolic assessment: a pilot study for feasibility, diagnostic validation, and outcome prediction","volume":"14","author":"Park","year":"2024","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.hipert.2025.06.002_bib0585","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCULATIONAHA.115.015884","article-title":"Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone","volume":"132","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0590","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/ehjci\/jead062","article-title":"Regional contributions to impaired myocardial mechanical function in heart failure with preserved ejection fraction","volume":"24","author":"Biering-S\u00f8rensen","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hipert.2025.06.002_bib0595","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ehf2.15120","article-title":"Electrocardiograph analysis for risk assessment of heart failure with preserved ejection fraction: a deep learning model","volume":"12","author":"Gao","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0600","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jacc.2025.01.030","article-title":"Ensemble deep learning algorithm for structural heart disease screening using electrocardiographic images: PRESENT SHD","volume":"12","author":"Dhingra","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hipert.2025.06.002_bib0605","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jacc.2024.05.003","article-title":"Transforming cardiovascular care with artificial intelligence: from discovery to practice: JACC state-of-the-art review","volume":"84","author":"Khera","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hipert.2025.06.002_bib0610","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cardfail.2008.05.002","article-title":"Correlation between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study","volume":"14","author":"Krittayaphong","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0615","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejheart.2004.03.015","article-title":"Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients","volume":"7","author":"Wei","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0620","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ejhf.3036","article-title":"Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: a clinical consensus statement from the Heart Failure Association of the ESC","volume":"25","author":"Bayes-Genis","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7583690","article-title":"Biomarkers of inflammation in left ventricular diastolic dysfunction","volume":"2","author":"Mocan","year":"2019","journal-title":"Dis Markers"},{"key":"10.1016\/j.hipert.2025.06.002_bib0630","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hipert.2025.06.002_bib0635","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/hc1202.105290","article-title":"New concepts in diastolic dysfunction and diastolic heart failure: Part II. Causal mechanisms and treatment","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0640","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCHEARTFAILURE.113.000568","article-title":"Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study","volume":"7","author":"Zakeri","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0645","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0650","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/ehjci\/jeae178","article-title":"Diastolic dysfunction in hypertension: a comprehensive review of pathophysiology, diagnosis, and treatment","volume":"25","author":"Ikast Ottosen","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hipert.2025.06.002_bib0655","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40292-022-00548-z","article-title":"Subclinical HMOD in hypertension: left ventricular diastolic dysfunction","volume":"29","author":"Bertacchini","year":"2022","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.hipert.2025.06.002_bib0660","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0665","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1532-429X-14-28","article-title":"Cardiovascular magnetic resonance in systemic hypertension","volume":"14","author":"Maceira","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hipert.2025.06.002_bib0670","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0675","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0680","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hipert.2025.06.002_bib0685","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2025.06.002_bib0690","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ajh.2010.235","article-title":"Diagnosis and management of left ventricular diastolic dysfunction in the hypertensive patient","volume":"24","author":"Galderisi","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hipert.2025.06.002_bib0695","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","article-title":"Renin\u2013angiotensin\u2013aldosterone system blockade for cardiovascular diseases: current status","volume":"160","author":"Ma","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.hipert.2025.06.002_bib0700","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/hc0902.104599","article-title":"Change in diastolic left ventricular filling after one year of antihypertensive treatment: the losartan intervention for endpoint reduction in hypertension (LIFE) study","volume":"105","author":"Wachtell","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0705","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199005103221904","article-title":"The effects of antihypertensive therapy on left ventricular mass in elderly patients","volume":"322","author":"Schulman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0710","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin\u2013angiotensin\u2013aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0715","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2006.01.009","article-title":"Rationale and design: the VALsartan in diastolic dysfunction (VALIDD) trial: evolving the management of diastolic dysfunction in hypertension","volume":"152","author":"Janardhanan","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.hipert.2025.06.002_bib0720","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"D\u00edez","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0725","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ejhf.2562","article-title":"Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment","volume":"24","author":"Inciardi","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0730","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijcard.2003.10.018","article-title":"Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan","volume":"97","author":"Mattioli","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hipert.2025.06.002_bib0735","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.hipert.2025.06.002_bib0740","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0745","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hipert.2025.06.002_bib0750","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8838026","article-title":"Diastolic Cardiac function improvement by liraglutide is mainly body weight reduction dependent but independently contributes to B-type natriuretic peptide reduction in patients with type 2 diabetes with preserved ejection fraction","volume":"2021","author":"Yagi","year":"2021","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.hipert.2025.06.002_bib0755","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0760","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/ejhf.2884","article-title":"Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: the DAPA-MODA study","volume":"25","author":"Pascual-Figal","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0765","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0770","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hipert.2025.06.002_bib0775","article-title":"Renal sympathetic denervation in patients with heart failure with preserved ejection fraction","volume":"14","author":"Kresoja","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hipert.2025.06.002_bib0780","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(22)02034-7","article-title":"Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial","volume":"400","author":"Schlaich","year":"2022","journal-title":"Lancet"}],"container-title":["Hipertensi\u00f3n y Riesgo Vascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183725000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1889183725000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:15:41Z","timestamp":1784596541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1889183725000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1889183725000388"],"URL":"https:\/\/doi.org\/10.1016\/j.hipert.2025.06.002","relation":{},"ISSN":["1889-1837"],"issn-type":[{"value":"1889-1837","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of diastolic dysfunction in arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Hipertensi\u00f3n y Riesgo Vascular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hipert.2025.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SEH-LELHA. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}